All lobbying filings

RED+BLUE STRATEGIES

RED+BLUE STRATEGIES filed a Q3 report for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) on October 20, 2026, reporting $60,000 in lobbying income.

Lobbying for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · PCMA represents pharmacy benefit managers, who administer the nation's covered Rx benefits

All filings by RED+BLUE STRATEGIES · Everything PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to pharmacy benefit managers and their role in public and private insurance coverage. Monitor issues and proposals related to health care price transparency.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.